Emma J Crosbie
Overview
Explore the profile of Emma J Crosbie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
192
Citations
4007
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
12.
Davies J, Sargent A, Pinggera E, Carter S, Gilham C, Sasieni P, et al.
BJOG
. 2024 Apr;
131(11):1456-1464.
PMID: 38660737
Objective: To evaluate the sensitivity of human papillomavirus (HPV) tested urine to detect high-grade cervical precancer (cervical intraepithelial neoplasia grade 2+ [CIN2+]) using two urine collection devices. Design: Randomised controlled...
13.
Walters B, Midwinter I, Chew-Graham C, Jordan K, Sharma G, Chappell L, et al.
Mayo Clin Proc Innov Qual Outcomes
. 2024 Mar;
8(2):188-199.
PMID: 38524280
This study aimed to systematically evaluate and quantify the risk of adverse maternal and neonatal outcomes in patients with pregnancy-associated cancer (PAC). This study was conducted from February 13, 2021,...
14.
Njoku K, Pierce A, Chiasserini D, Geary B, Campbell A, Kelsall J, et al.
EBioMedicine
. 2024 Mar;
102:105064.
PMID: 38513301
Background: The anatomical continuity between the uterine cavity and the lower genital tract allows for the exploitation of uterine-derived biomaterial in cervico-vaginal fluid for endometrial cancer detection based on non-invasive...
15.
16.
Kaya M, Post C, Tops C, Nielsen M, Crosbie E, Leary A, et al.
Mod Pathol
. 2024 Jan;
37(3):100423.
PMID: 38191122
Universal tumor screening in endometrial carcinoma (EC) is increasingly adopted to identify individuals at risk of Lynch syndrome (LS). These cases involve mismatch repair-deficient (MMRd) EC without MLH1 promoter hypermethylation...
17.
Urwin S, Gillibrand S, Davies J, Crosbie E
J Public Health (Oxf)
. 2023 Dec;
46(1):e43-e50.
PMID: 38148290
Background: Cervical cancer remains an important global public health concern. Understanding the factors contributing to a decline in screening uptake in high-income countries is fundamental to improving screening rates. We...
18.
Jones O, Young H, Clarke H, Crosbie E, Sivalingam V
Int J Gynecol Cancer
. 2023 Dec;
34(1):73-79.
PMID: 38088173
Objective: To develop and test a novel instrument to assess public awareness of endometrial cancer symptoms and risk factors in a UK population. Methods: A 36-item questionnaire was developed through...
19.
Kitson S, Crosbie E, Evans D, Lophatananon A, Muir K, Ashcroft D, et al.
BJOG
. 2023 Dec;
131(7):996-1005.
PMID: 38073256
Objectives: Develop an endometrial cancer risk prediction model and externally validate it for UK primary care use. Design: Cohort study. Setting: The UK Biobank was used for model development and...
20.
Whittaker M, Davies J, Sargent A, Sawyer M, Crosbie E
BJOG
. 2023 Nov;
131(5):699-708.
PMID: 38012840
Objective: To understand whether self-sampling can reduce carbon emissions (CO e) from the NHS cervical screening programme (NHSCSP) by comparing the carbon footprint of three sampling strategies: routine cervical sampling,...